Avita Medical Inc Share Price and Company Fundamentals
Last traded: Today at 3:25 AM
AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitiligo lesions. It also provides RECALL autologous cell harvesting device, which can treat areas of up to 1,920 cm2; RECELL autologous cell harvesting device with ease-of-use, an enhanced ease-of-use device that can treat areas of up to 1,920 cm²; and RECELL GO mini autologous cell harvesting device, a line extension of the RECELL GO system to treat smaller wounds up to 480 cm2, as well as RECELL GO autologous cell harvesting device consisting of RECELL GO processing device, which controls and manages the pressure applied to disaggregate the donor skin cells and controls the incubation time of the RECELL Enzyme to optimize cell yield and promote cell viability; and RECELL GO preparation kit, which can treat areas up to 1,920 cm2. In addition, the company markets, sells, and distributes PermeaDerm, a biosynthetic wound matrix; and Cohealyx, a collagen-based dermal matrix. It serves hospitals, treatment centers, and distributors. The company was formerly known as AVITA Therapeutics, Inc. and changed its name to AVITA Medical, Inc. in December 2020. AVITA Medical, Inc. is headquartered in Valencia, California.
Key Metrics
PE ratio
-
PB ratio
-
Dividend yield
-
Beta
1.80
Market cap
$186.01M
Enterprise value
$58.66M
Company profile
| Industry / Sector | Medical Devices / Healthcare |
|---|---|
| Full time employees | 260 |
| Website | https://avitamedical.com |
| Mailing address | 28159 Avenue Stanford Suite 220 Valencia CA 91355 United States |
| Phone / Fax | 661 367 9170 / 661 749 9430 |
Dividends
More: Avita Medical Inc Dividend history, yield and payout ratio
Dividend yield
-
Dividend amount
$-
Payout ratio
0.00%
5Y Avg. yield
-%
Avita Medical Inc paid $- dividend and the ex-dividend date was -.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.AVH dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Feb 2026, following are the company executives and directors listed on Avita Medical Inc.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Cary G. Vance | Independent Non-Executive Chairman & Interim CEO | 59 | |
| Mr. David O'Toole | Chief Financial Officer | 66 | |
| Ms. Nicole Linda Kelsey | Chief Legal & Compliance Officer and Corporate Secretary | 58 | |
| David Melbye | Senior Vice President of Operations | ||
| Dr. Katie Bush Ph.D. | Senior Vice President of Scientific & Medical Affairs | ||
| Mr. Ben Atkins | Vice President of Investor Relations & Corporate Communications | ||
| Ms. Debbie Garner | Senior Vice President of Global Marketing & Strategy | ||
| Dr. Niraj Doshi J.D., P.M.P., Ph.D. | Senior VP of R&D, Program Management and Business Development | ||
| Mr. Ron Lagerquist | Senior Vice President of Quality Assurance & Regulatory Affairs | ||
| Ms. Robin VanDenburgh | Senior Vice President of U.S. Commercial Sales |
Profitability and management effectiveness
Profit margin
-67.06%
Operating margin
-53.65%
Return on assets
-36.33%
Return on equity
-1746.27%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Avita Medical Inc is 186.01M and its enterprise value is 58.66M. The enterprise value to revenue ratio of AVH is 0.81. The enterprise value to EBITDA ratio of AVH is -1.47.
The AVH's stocks Beta value is 1.80 making it 80% more volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Avita Medical Inc (AVH)
Avita Medical Inc (ASX:AVH) Frequently Asked Questions
1. What is Avita Medical Inc's Stock Symbol?
Avita Medical Inc trades on ASX under the ticker symbol "AVH".
2. What is Avita Medical Inc's stock price today?
One share of AVH stock can currently be purchased for approximately $1.22.
3. How can I contact Avita Medical Inc?
Avita Medical Inc's mailing address is 28159 Avenue Stanford Suite 220 Valencia CA 91355 United States. The company can be reached via phone at 661 367 9170.
4. What is Avita Medical Inc's official website?
The official website of Avita Medical Inc is https://avitamedical.com.